Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Influenza

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 299 articles:
HTML format
Text format



Single Articles


    January 2018
  1. VER LS, Marcos-Villar L, Landeras-Bueno S, Nieto A, et al
    Correction for Ver et al., "The Cellular Factor NXP2/MORC3 Is a Positive Regulator of Influenza Virus Multiplication".
    J Virol. 2017;92.
    PubMed     Text format    


    December 2017
  2. CHAUCHE C, Nogales A, Zhu H, Goldfarb D, et al
    Mammalian adaptation of an avian influenza A virus involves stepwise changes in NS1.
    J Virol. 2017 Dec 13. pii: JVI.01875-17. doi: 10.1128/JVI.01875.
    PubMed     Text format     Abstract available


  3. TURKINGTON HL, Juozapaitis M, Tsolakos N, Corrales-Aguilar E, et al
    Unexpected Functional Divergence of Bat Influenza Virus NS1 Proteins.
    J Virol. 2017 Dec 13. pii: JVI.02097-17. doi: 10.1128/JVI.02097.
    PubMed     Text format     Abstract available


  4. CHEN C, Liu L, Xiao Y, Cui S, et al
    Structural insight into a human neutralizing antibody against influenza virus H7N9.
    J Virol. 2017 Dec 6. pii: JVI.01850-17. doi: 10.1128/JVI.01850.
    PubMed     Text format     Abstract available


  5. RICHARD M, Herfst S, Tao H, Jacobs NT, et al
    Influenza A virus reassortment is limited by anatomical compartmentalization following co-infection via distinct routes.
    J Virol. 2017 Dec 6. pii: JVI.02063-17. doi: 10.1128/JVI.02063.
    PubMed     Text format     Abstract available


  6. XIAO J, Rijal P, Schimanski L, Tharkeshwar AK, et al
    Characterization of an influenza virus pseudotyped with Ebolavirus glycoprotein.
    J Virol. 2017 Dec 6. pii: JVI.00941-17. doi: 10.1128/JVI.00941.
    PubMed     Text format     Abstract available


  7. ZHONG G, Le MQ, Lopes TJS, Halfmann P, et al
    Mutations in the PA Protein of Avian H5N1 Influenza Viruses Affect Polymerase Activity and Mouse Virulence.
    J Virol. 2017 Dec 6. pii: JVI.01557-17. doi: 10.1128/JVI.01557.
    PubMed     Text format     Abstract available


  8. IWATSUKI-HORIMOTO K, Nakajima N, Ichiko Y, Sakai-Tagawa Y, et al
    Syrian hamster as an animal model for the study of human influenza virus infection.
    J Virol. 2017 Dec 6. pii: JVI.01693-17. doi: 10.1128/JVI.01693.
    PubMed     Text format     Abstract available


  9. YANG L, Zhu W, Li X, Chen M, et al
    Genesis and Spread of Newly Emerged Highly Pathogenic H7N9 Avian Viruses in Mainland China.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    November 2017
  10. SHIL NK, Pokharel SM, Banerjee AK, Hoffman M, et al
    Inflammasome antagonism by human parainfluenza virus type 3 C protein.
    J Virol. 2017 Nov 29. pii: JVI.01776-17. doi: 10.1128/JVI.01776.
    PubMed     Text format     Abstract available


  11. WAN H, Qi L, Gao J, Couzens LK, et al
    Comparison of the Efficacy of N9 Neuraminidase-specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.
    J Virol. 2017 Nov 22. pii: JVI.01588-17. doi: 10.1128/JVI.01588.
    PubMed     Text format     Abstract available


  12. SU WC, Yu WY, Huang SH, Lai MMC, et al
    Ubiquitination of the Cytoplasmic Domain of Influenza A Virus M2 Protein is Crucial for Production of Infectious Virus Particles.
    J Virol. 2017 Nov 22. pii: JVI.01972-17. doi: 10.1128/JVI.01972.
    PubMed     Text format     Abstract available


  13. JOB ER, Schotsaert M, Ibanez LI, Smet A, et al
    Antibodies directed towards neuraminidase N1 control disease in a mouse model of influenza.
    J Virol. 2017 Nov 22. pii: JVI.01584-17. doi: 10.1128/JVI.01584.
    PubMed     Text format     Abstract available


  14. TE VELTHUIS AJW, Oymans J
    Initiation, elongation and realignment during influenza virus mRNA synthesis.
    J Virol. 2017 Nov 15. pii: JVI.01775-17. doi: 10.1128/JVI.01775.
    PubMed     Text format     Abstract available


  15. SAKAI T, Takagi H, Muraki Y, Saito M, et al
    Unique directional motility of influenza C virus controlled by its filamentous morphology and short-range motions.
    J Virol. 2017 Nov 8. pii: JVI.01522-17. doi: 10.1128/JVI.01522.
    PubMed     Text format     Abstract available


  16. OYMANS J, Te Velthuis AJW
    A mechanism for prime-realignment during influenza A virus replication.
    J Virol. 2017 Nov 8. pii: JVI.01773-17. doi: 10.1128/JVI.01773.
    PubMed     Text format     Abstract available


  17. WEN F, Li L, Zhao N, Chiang MJ, et al
    A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 influenza A Virus in Cells.
    J Virol. 2017 Nov 8. pii: JVI.01621-17. doi: 10.1128/JVI.01621.
    PubMed     Text format     Abstract available


  18. WARING BM, Sjaastad LE, Fiege JK, Fay EJ, et al
    microRNA-based attenuation of influenza virus across susceptible hosts.
    J Virol. 2017 Nov 1. pii: JVI.01741-17. doi: 10.1128/JVI.01741.
    PubMed     Text format     Abstract available


  19. VAN ERP EA, van Kasteren PB, Guichelaar T, Ahout IML, et al
    In Vitro Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    October 2017
  20. QI W, Jia W, Liu D, Li J, et al
    Emergence and adaptation of a novel highly pathogenic H7N9 influenza virus in birds and humans from a 2013-human-infecting low pathogenic ancestor.
    J Virol. 2017 Oct 25. pii: JVI.00921-17. doi: 10.1128/JVI.00921.
    PubMed     Text format     Abstract available


  21. CHOI WS, Jeong JH, Kwon JJ, Ahn SJ, et al
    Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6 and N8 Neuraminidase Subtypes.
    J Virol. 2017 Oct 18. pii: JVI.01580-17. doi: 10.1128/JVI.01580.
    PubMed     Text format     Abstract available


  22. LIU H, Grantham ML, Pekosz A
    Mutations in the Influenza A virus M1 protein enhance virus budding to complement lethal mutations in the M2 cytoplasmic tail.
    J Virol. 2017 Oct 18. pii: JVI.00858-17. doi: 10.1128/JVI.00858.
    PubMed     Text format     Abstract available


  23. SUTTON TC, Lamirande EW, Bock KW, Moore IN, et al
    In vitro neutralization is not predictive of prophylactic efficacy of broadly neutralizing monoclonal antibodies CR6261 and CR9114 against lethal H2 influenza virus challenge in mice.
    J Virol. 2017 Oct 18. pii: JVI.01603-17. doi: 10.1128/JVI.01603.
    PubMed     Text format     Abstract available


  24. FRABUTT DA, Wang B, Riaz S, Schwartz RC, et al
    Innate sensing of influenza A virus hemagglutinin glycoproteins by the host endoplasmic reticulum (ER) stress pathway triggers a potent antiviral response via ER-associated protein degradation.
    J Virol. 2017 Oct 18. pii: JVI.01690-17. doi: 10.1128/JVI.01690.
    PubMed     Text format     Abstract available


  25. WONG TM, Allen JD, Bebin-Blackwell AG, Carter DM, et al
    COBRA HA elicits hemagglutination-inhibition antibodies against a panel of H3N2 influenza virus co-circulating variants.
    J Virol. 2017 Oct 4. pii: JVI.01581-17. doi: 10.1128/JVI.01581.
    PubMed     Text format     Abstract available


  26. CARTER DM, Darby CA, Johnson SK, Carlock MA, et al
    Elicitation of protective antibodies against a broad panel of H1N1 viruses in ferrets pre-immune to historical H1N1 influenza viruses.
    J Virol. 2017 Oct 4. pii: JVI.01283-17. doi: 10.1128/JVI.01283.
    PubMed     Text format     Abstract available


    September 2017
  27. MOONEY AJ, Gabbard JD, Li Z, Dlugolenski DA, et al
    Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    J Virol. 2017 Sep 20. pii: JVI.01579-17. doi: 10.1128/JVI.01579.
    PubMed     Text format     Abstract available


  28. ANDERSEN TK, Zhou F, Cox R, Bogen B, et al
    A DNA vaccine that targets hemagglutinin to antigen presenting cells protects mice against H7 influenza.
    J Virol. 2017 Sep 20. pii: JVI.01340-17. doi: 10.1128/JVI.01340.
    PubMed     Text format     Abstract available


  29. NAGUIB MM, Ulrich R, Kasbohm E, Eng CLP, et al
    Natural reassortants between potentially zoonotic avian influenza viruses H5N1 and H9N2 from Egypt display distinct pathogenic phenotypes in experimentally infected chickens and ferrets.
    J Virol. 2017 Sep 20. pii: JVI.01300-17. doi: 10.1128/JVI.01300.
    PubMed     Text format     Abstract available


  30. KEEF E, Zhang LA, Swigon D, Urbano A, et al
    Discrete dynamical modeling of influenza infection suggests age-dependent differences in immunity.
    J Virol. 2017 Sep 13. pii: JVI.00395-17. doi: 10.1128/JVI.00395.
    PubMed     Text format     Abstract available


  31. GOTO T, Shimotai Y, Matsuzaki Y, Muraki Y, et al
    Effect of the phosphorylation of the CM2 protein on influenza C virus replication.
    J Virol. 2017 Sep 6. pii: JVI.00773-17. doi: 10.1128/JVI.00773.
    PubMed     Text format     Abstract available


    August 2017
  32. BROOKE CB
    Population diversity and collective interactions during influenza virus replication and evolution.
    J Virol. 2017 Aug 30. pii: JVI.01164-17. doi: 10.1128/JVI.01164.
    PubMed     Text format     Abstract available


  33. NOGALES A, Chauche C, DeDiego ML, Topham DJ, et al
    Amino acid substitution K186E in the canine influenza virus H3N8 NS1 protein restores its ability to inhibit host gene expression.
    J Virol. 2017 Aug 23. pii: JVI.00877-17. doi: 10.1128/JVI.00877.
    PubMed     Text format     Abstract available


  34. LIU X, Liang B, Ngwuta J, Liu X, et al
    Attenuated human parainfluenza virus type 1 (HPIV1) expressing the respiratory syncytial virus (RSV) fusion F glycoprotein from an added gene: effects of pre-fusion stabilization and packaging of RSV F.
    J Virol. 2017 Aug 23. pii: JVI.01101-17. doi: 10.1128/JVI.01101.
    PubMed     Text format     Abstract available


  35. LOPES AM, Domingues P, Zell R, Hale BG, et al
    Structure-Guided Functional Annotation of the Influenza A Virus NS1 Protein Reveals Dynamic Evolution of the p85beta-Binding Site During Circulation in Humans.
    J Virol. 2017 Aug 16. pii: JVI.01081-17. doi: 10.1128/JVI.01081.
    PubMed     Text format     Abstract available


  36. WANG Z, Yang H, Chen Y, Tao S, et al
    A Single-Amino-Acid Substitution at Position 225 in HA Alters the Transmissibility of Eurasian Avian-like H1N1 Swine Influenza Virus in Guinea Pigs.
    J Virol. 2017 Aug 16. pii: JVI.00800-17. doi: 10.1128/JVI.00800.
    PubMed     Text format     Abstract available


  37. SUN H, Blackmon S, Yang G, Waters K, et al
    Zoonotic Risk, Pathogenesis, and Transmission of Avian-Origin H3N2 Canine Influenza Virus.
    J Virol. 2017 Aug 16. pii: JVI.00637-17. doi: 10.1128/JVI.00637.
    PubMed     Text format     Abstract available


  38. CHLANDA P, Mekhedov E, Waters H, Sodt A, et al
    Palmitoylation contributes to membrane curvature in Influenza A virus assembly and hemagglutinin-mediated membrane fusion.
    J Virol. 2017 Aug 9. pii: JVI.00947-17. doi: 10.1128/JVI.00947.
    PubMed     Text format     Abstract available


  39. BERTRAN K, Lee DH, Pantin-Jackwood MJ, Spackman E, et al
    Pathobiology of clade 2.3.4.4 H5Nx high pathogenicity avian influenza virus infections in minor gallinaceous poultry supports early backyard flock introductions in Western U.S., 2014-2015.
    J Virol. 2017 Aug 9. pii: JVI.00960-17. doi: 10.1128/JVI.00960.
    PubMed     Text format     Abstract available


  40. CHEN SC, Jeng KS, Lai MMC
    Zinc finger-containing cellular transcription corepressor ZBTB25 promotes influenza virus RNA transcription and is a target for zinc-ejector drugs.
    J Virol. 2017 Aug 2. pii: JVI.00842-17. doi: 10.1128/JVI.00842.
    PubMed     Text format     Abstract available


  41. KAMAL RP, Blanchfield K, Belser JA, Music N, et al
    Inactivated H7 influenza virus vaccines protect mice despite low levels of neutralizing antibodies.
    J Virol. 2017 Aug 2. pii: JVI.01202-17. doi: 10.1128/JVI.01202.
    PubMed     Text format     Abstract available


    July 2017
  42. PHAN SI, Zengel JR, Wei H, Li Z, et al
    Parainfluenza virus 5 (PIV5) expressing wild-type or pre-fusion respiratory syncytial virus (RSV) fusion protein protect mice and cotton rats from RSV challenge.
    J Virol. 2017 Jul 26. pii: JVI.00560-17. doi: 10.1128/JVI.00560.
    PubMed     Text format     Abstract available


  43. PHAN SI, Adam CM, Chen Z, Citron M, et al
    The genetic stability of PIV5-vectored RSV vaccine candidates after in vitro and in vivo passage.
    J Virol. 2017 Jul 26. pii: JVI.00559-17. doi: 10.1128/JVI.00559.
    PubMed     Text format     Abstract available


  44. NTURIBI E, Bhagwat AR, Coburn S, Myerburg MM, et al
    Intracellular Colocalization of Influenza Viral RNA and Rab11A is Dependent upon Microtubule Filaments.
    J Virol. 2017 Jul 19. pii: JVI.01179-17. doi: 10.1128/JVI.01179.
    PubMed     Text format     Abstract available


  45. SUTTON TC, Lamirande EW, Czako R, Subbarao K, et al
    Evaluation of the biological properties and cross-reactive antibody response to H10 influenza viruses in ferrets.
    J Virol. 2017 Jul 12. pii: JVI.00895-17. doi: 10.1128/JVI.00895.
    PubMed     Text format     Abstract available


    June 2017
  46. DIAZ A, Marthaler D, Culhane M, Sreevatsan S, et al
    Complete Genome Sequencing of Influenza A Viruses within Swine Farrow-to-Wean Farms Reveals the Emergence, Persistence, and Subsidence of Diverse Viral Genotypes.
    J Virol. 2017 Jun 28. pii: JVI.00745-17. doi: 10.1128/JVI.00745.
    PubMed     Text format     Abstract available


  47. PHIPPS KL, Marshall N, Tao H, Danzy S, et al
    Seasonal H3N2 and 2009 pandemic H1N1 influenza A viruses reassort efficiently but produce attenuated progeny.
    J Virol. 2017 Jun 21. pii: JVI.00830-17. doi: 10.1128/JVI.00830.
    PubMed     Text format     Abstract available


  48. CLARK AM, Nogales A, Martinez-Sobrido L, Topham DJ, et al
    Functional evolution of influenza NS1 protein in currently circulating human 2009 pandemic H1N1 viruses.
    J Virol. 2017 Jun 21. pii: JVI.00721-17. doi: 10.1128/JVI.00721.
    PubMed     Text format     Abstract available


  49. NOGALES A, Rodriguez L, DeDiego ML, Topham DJ, et al
    Interplay of PA-X and NS1 proteins in replication and pathogenesis of a temperature-sensitive 2009 pandemic H1N1 influenza A virus.
    J Virol. 2017 Jun 21. pii: JVI.00720-17. doi: 10.1128/JVI.00720.
    PubMed     Text format     Abstract available


  50. NILSSON BE, Te Velthuis AJW, Fodor E
    Erratum for Nilsson et al., "Role of the PB2 627 Domain in Influenza A Virus Polymerase Function".
    J Virol. 2017;91.
    PubMed     Text format    


  51. MAGNEN M, Gueugnon F, Guillon A, Baranek T, et al
    Kallikrein-related peptidase 5 contributes to H3N2 influenza virus infection in human lungs.
    J Virol. 2017 Jun 14. pii: JVI.00421-17. doi: 10.1128/JVI.00421.
    PubMed     Text format     Abstract available


  52. WANG D, Phan S, DiStefano DJ, Citron MP, et al
    A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    May 2017
  53. ZHAO M, Zheng ZZ, Chen M, Modjarrad K, et al
    Discovery of a Prefusion RSV F-Specific Monoclonal Antibody that Provides Greater in vivo Protection than the Murine Precursor of Palivizumab.
    J Virol. 2017 May 24. pii: JVI.00176-17. doi: 10.1128/JVI.00176.
    PubMed     Text format     Abstract available


  54. PEREIRA CF, Read EKC, Wise HM, Amorim MJ, et al
    The influenza A virus NS1 protein promotes efficient nuclear export of unspliced viral M1 mRNA.
    J Virol. 2017 May 17. pii: JVI.00528-17. doi: 10.1128/JVI.00528.
    PubMed     Text format     Abstract available


  55. BELSER JA, Pulit-Penaloza JA, Sun X, Brock N, et al
    A novel A(H7N2) influenza virus isolated from a veterinarian caring for cats in a New York City animal shelter causes mild disease and transmits poorly in the ferret model.
    J Virol. 2017 May 17. pii: JVI.00672-17. doi: 10.1128/JVI.00672.
    PubMed     Text format     Abstract available


  56. ZHANG L, Li H, Hai Y, Yin W, et al
    CpG in Combination with an Inhibitor of Notch Signaling Suppresses Formalin-Inactivated Respiratory Syncytial Virus-Enhanced Airway Hyperresponsiveness and Inflammation by Inhibiting Th17 Memory Responses and Promoting Tissue-Resident Memory Cells in
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  57. BOONNAK K, Matsuoka Y, Wang W, Suguitan AL Jr, et al
    Development of clade-specific and broadly reactive live attenuated influenza virus vaccines against rapidly evolving H5 subtype viruses.
    J Virol. 2017 May 10. pii: JVI.00547-17. doi: 10.1128/JVI.00547.
    PubMed     Text format     Abstract available


  58. FUCHS J, Holzer M, Schilling M, Patzina C, et al
    Evolution and antiviral specificity of interferon-induced Mx proteins of bats against Ebola-, Influenza-, and other RNA viruses.
    J Virol. 2017 May 10. pii: JVI.00361-17. doi: 10.1128/JVI.00361.
    PubMed     Text format     Abstract available


  59. WU Y, Wang J, Fan S, Chen R, et al
    Structural Definition of Duck MHC class I Molecules that might explain efficient CTL Immunity against Influenza A Virus.
    J Virol. 2017 May 10. pii: JVI.02511-16. doi: 10.1128/JVI.02511.
    PubMed     Text format     Abstract available


  60. PEACOCK TP, Benton DJ, James J, Sadeyen JR, et al
    Immune escape variants of H9N2 influenza viruses containing deletions at the haemagglutinin receptor binding site retain fitness in vivo and display enhanced zoonotic characteristics.
    J Virol. 2017 May 3. pii: JVI.00218-17. doi: 10.1128/JVI.00218.
    PubMed     Text format     Abstract available


  61. SOBEL LEONARD A, Weissman D, Greenbaum B, Ghedin E, et al
    Transmission Bottleneck Size Estimation from Pathogen Deep-Sequencing Data, with an Application to Human Influenza A Virus.
    J Virol. 2017 May 3. pii: JVI.00171-17. doi: 10.1128/JVI.00171.
    PubMed     Text format     Abstract available


  62. GUEDAN A, Swieboda D, Charles M, Toussaint M, et al
    Investigation of the Role of Protein Kinase D in Human Rhinovirus Replication.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    April 2017
  63. IVINSON K, Deliyannis G, McNabb L, Grollo L, et al
    Salivary blockade protects the lower respiratory tract of mice from lethal influenza.
    J Virol. 2017 Apr 26. pii: JVI.00624-17. doi: 10.1128/JVI.00624.
    PubMed     Text format     Abstract available


  64. GILBERTSON B, Ng WC, Crawford S, McKimm-Breschkin JL, et al
    Mouse saliva inhibits transit of influenza virus to the lower respiratory tract by efficiently blocking influenza neuraminidase activity.
    J Virol. 2017 Apr 26. pii: JVI.00145-17. doi: 10.1128/JVI.00145.
    PubMed     Text format     Abstract available


  65. WATTERS K, Inankur B, Gardiner JC, Warrick J, et al
    Differential Disruption of Nucleocytoplasmic Trafficking Pathways by Rhinovirus 2A Proteases.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  66. TZARUM N, McBride R, Nycholat CM, Paulson JC, et al
    Unique structural features of influenza H15 HA.
    J Virol. 2017 Apr 12. pii: JVI.00046-17. doi: 10.1128/JVI.00046.
    PubMed     Text format     Abstract available


  67. SHIN D, Lee J, Park JH, Min JY, et al
    Double PHD Fingers 2 (DPF2) Promotes the Immune Escape of Influenza Virus by Suppressing Interferon-beta Production.
    J Virol. 2017 Apr 12. pii: JVI.02260-16. doi: 10.1128/JVI.02260.
    PubMed     Text format     Abstract available


  68. DU Y, Chen M, Yang J, Jia Y, et al
    Molecular Evolution and Emergence of H5N6 Avian Influenza Virus in Central China.
    J Virol. 2017 Apr 12. pii: JVI.00143-17. doi: 10.1128/JVI.00143.
    PubMed     Text format     Abstract available


  69. SANTOS JJ, Finch C, Sutton T, Obadan A, et al
    Development of an alternative modified live Influenza B virus vaccine.
    J Virol. 2017 Apr 5. pii: JVI.00056-17. doi: 10.1128/JVI.00056.
    PubMed     Text format     Abstract available


  70. ZHAO D, Liang L, Wang S, Nakao T, et al
    Glycosylation of the Hemagglutinin Protein of H5N1 Influenza Virus Increases Its Virulence in Mice by Exacerbating the Host Immune Response.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  71. PALMENBERG AC
    Rhinovirus C, Asthma, and Cell Surface Expression of Virus Receptor CDHR3.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  72. LEWIS-ROGERS N, Seger J, Adler FR
    Human Rhinovirus Diversity and Evolution: How Strange the Change from Major to Minor.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    March 2017
  73. BOBONE S, Hilsch M, Storm J, Dunsing V, et al
    Phosphatidylserine Lateral Organization Influences the Interaction of Influenza Matrix Protein 1 with Lipid Membranes.
    J Virol. 2017 Mar 29. pii: JVI.00267-17. doi: 10.1128/JVI.00267.
    PubMed     Text format     Abstract available


  74. GERLACH T, Hensen L, Matrosovich T, Bergmann J, et al
    pH-optimum of hemagglutinin-mediated membrane fusion determines sensitivity of influenza A viruses to the interferon-induced antiviral state and IFITMs.
    J Virol. 2017 Mar 29. pii: JVI.00246-17. doi: 10.1128/JVI.00246.
    PubMed     Text format     Abstract available


  75. BENTON DJ, Wharton SA, Martin SR, McCauley JW, et al
    Role of Neuraminidase in Influenza A(H7N9) Receptor Binding.
    J Virol. 2017 Mar 29. pii: JVI.02293-16. doi: 10.1128/JVI.02293.
    PubMed     Text format     Abstract available


  76. ERMLER M, Kirkpatrick E, Sun W, Hai R, et al
    Chimeric hemagglutinin constructs induce broad protection against influenza B virus challenge in the mouse model.
    J Virol. 2017 Mar 29. pii: JVI.00286-17. doi: 10.1128/JVI.00286.
    PubMed     Text format     Abstract available


  77. WANG S, Ren H, Jiang W, Chen H, et al
    Divergent requirement of Fc-FcgammaR interactions for in vivo protection against influenza viruses by two pan-H5 hemagglutinin antibodies.
    J Virol. 2017 Mar 22. pii: JVI.02065-16. doi: 10.1128/JVI.02065.
    PubMed     Text format     Abstract available


  78. WHITE MC, Steel J, Lowen AC
    Heterologous packaging signals on HA, but not NA or NS, limit influenza A virus reassortment.
    J Virol. 2017 Mar 22. pii: JVI.00195-17. doi: 10.1128/JVI.00195.
    PubMed     Text format     Abstract available


  79. COBBIN JC, Alfelali M, Barasheed O, Taylor J, et al
    Multiple sources of genetic diversity of influenza A viruses during the Hajj.
    J Virol. 2017 Mar 22. pii: JVI.00096-17. doi: 10.1128/JVI.00096.
    PubMed     Text format     Abstract available


  80. KWON HI, Kim YI, Park SJ, Song MS, et al
    Evaluation of the immune responses to and cross-protective efficacy of Eurasian H7 avian influenza viruses.
    J Virol. 2017 Mar 22. pii: JVI.02259-16. doi: 10.1128/JVI.02259.
    PubMed     Text format     Abstract available


  81. TIAN B, Yang J, Zhao Y, Ivanciuc T, et al
    BRD4 Couples NF-kappaB/RelA with Airway Inflammation and the IRF-RIG-I Amplification Loop in Respiratory Syncytial Virus Infection.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  82. BOYOGLU-BARNUM S, Todd SO, Meng J, Barnum TR, et al
    Mutating the CX3C motif in the G protein should make a live respiratory syncytial virus vaccine safer and more effective.
    J Virol. 2017 Mar 8. pii: JVI.02059-16. doi: 10.1128/JVI.02059.
    PubMed     Text format     Abstract available


  83. LINGEMANN M, Liu X, Surman S, Liang B, et al
    Attenuated Human Parainfluenza Virus type 1 expressing Ebola Virus Glycoprotein GP Administered Intranasally is Immunogenic in African Green Monkeys.
    J Virol. 2017 Mar 1. pii: JVI.02469-16. doi: 10.1128/JVI.02469.
    PubMed     Text format     Abstract available


  84. SCHIERHORN KL, Jolmes F, Bespalowa J, Saenger S, et al
    Influenza A virus virulence depends on two amino acids in the N-terminal domain of its NS1 protein facilitating inhibition of PKR.
    J Virol. 2017 Mar 1. pii: JVI.00198-17. doi: 10.1128/JVI.00198.
    PubMed     Text format     Abstract available


  85. ZHANG Z, Dong Z, Wei Q, Carr MJ, et al
    A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
    J Virol. 2017 Mar 1. pii: JVI.02450-16. doi: 10.1128/JVI.02450.
    PubMed     Text format     Abstract available


  86. WIEGAND MA, Gori-Savellini G, Gandolfo C, Papa G, et al
    Respiratory syncytial virus (RSV) vaccine vectored by a stable chimeric and replication-deficient Sendai virus protects mice without inducing enhanced disease.
    J Virol. 2017 Mar 1. pii: JVI.02298-16. doi: 10.1128/JVI.02298.
    PubMed     Text format     Abstract available


    February 2017
  87. LESER GP, Lamb RA
    The lateral organization of influenza virus proteins in the budozone region of the plasma membrane.
    J Virol. 2017 Feb 15. pii: JVI.02104-16. doi: 10.1128/JVI.02104.
    PubMed     Text format     Abstract available


  88. XU Y, Ramey AM, Bowman AS, DeLiberto TJ, et al
    Low Pathogenic Influenza A Viruses in North American Diving Ducks Contribute to the Emergence of a Novel Highly Pathogenic Influenza A(H7N8) Virus.
    J Virol. 2017 Feb 15. pii: JVI.02208-16. doi: 10.1128/JVI.02208.
    PubMed     Text format     Abstract available


  89. DAI M, McBride R, Dortmans JC, Peng W, et al
    Mutation of the 2nd Sialic Acid-Binding Site Resulting in Reduced Neuraminidase Activity Preceded Emergence of H7N9 Influenza A Virus.
    J Virol. 2017 Feb 15. pii: JVI.00049-17. doi: 10.1128/JVI.00049.
    PubMed     Text format     Abstract available


  90. JIANG W, Wang S, Chen H, Ren H, et al
    A bivalent heterologous DNA-virus-like particles prime-boost vaccine elicits broad protection against both groups 1 and 2 influenza A viruses.
    J Virol. 2017 Feb 8. pii: JVI.02052-16. doi: 10.1128/JVI.02052.
    PubMed     Text format     Abstract available


  91. MATSUMOTO Y, Ohta K, Kolakofsky D, Nishio M, et al
    A point mutation in the RNA-binding domain of human parainfluenza virus type 2 nucleoprotein elicits an abnormally enhanced polymerase activity.
    J Virol. 2017 Feb 8. pii: JVI.02203-16. doi: 10.1128/JVI.02203.
    PubMed     Text format     Abstract available


  92. HALL OJ, Nachbagauer R, Vermillion MS, Fink AL, et al
    Progesterone-based contraceptives reduce adaptive immune responses and protection against sequential influenza A virus infections.
    J Virol. 2017 Feb 8. pii: JVI.02160-16. doi: 10.1128/JVI.02160.
    PubMed     Text format     Abstract available


  93. PU J, Sun H, Qu Y, Wang C, et al
    M gene reassortment in H9N2 influenza virus promotes early infection and replication: contribution to rising virus prevalence in chickens in China.
    J Virol. 2017 Feb 1. pii: JVI.02055-16. doi: 10.1128/JVI.02055.
    PubMed     Text format     Abstract available


  94. YANG W, Punyadarsaniya D, Lambertz RL, Lee DC, et al
    Mutations during the adaptation of H9N2 avian influenza virus to the respiratory epithelium of pigs enhance the sialic acid binding activity and the virulence in mice.
    J Virol. 2017 Feb 1. pii: JVI.02125-16. doi: 10.1128/JVI.02125.
    PubMed     Text format     Abstract available


  95. SCHNEIDER-OHRUM K, Cayatte C, Snell Bennett A, Manohar Rajani G, et al
    Immunization with low doses of recombinant post-fusion or pre-fusion RSV F primes for vaccine-enhanced disease in the cotton rat model independent of the presence of a Th1-biasing (GLA-SE) or Th2-biasing (Alum) adjuvant.
    J Virol. 2017 Feb 1. pii: JVI.02180-16. doi: 10.1128/JVI.02180.
    PubMed     Text format     Abstract available


    January 2017
  96. NILSSON BE, Te Velthuis AJ, Fodor E
    The role of the PB2 627-domain in influenza A virus polymerase function.
    J Virol. 2017 Jan 25. pii: JVI.02467-16. doi: 10.1128/JVI.02467.
    PubMed     Text format     Abstract available


  97. TANG X, Yang Y, Xia X, Zhang C, et al
    Recombinant adenoviruses displaying matrix 2 ectodomain epitopes (M2e) on their fiber proteins as universal influenza vaccines.
    J Virol. 2017 Jan 18. pii: JVI.02462-16. doi: 10.1128/JVI.02462.
    PubMed     Text format     Abstract available


  98. VAN DEN HOECKE S, Ehrhardt K, Kolpe A, El Bakkouri K, et al
    Hierarchical and redundant roles of activating FcgammaRs in protection against influenza disease by M2e-specific IgG1 and IgG2a antibodies.
    J Virol. 2017 Jan 11. pii: JVI.02500-16. doi: 10.1128/JVI.02500.
    PubMed     Text format     Abstract available


  99. VAN DEN POL AN, Mao G, Chattopadhyay A, Rose JK, et al
    Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain.
    J Virol. 2017 Jan 11. pii: JVI.02154-16. doi: 10.1128/JVI.02154.
    PubMed     Text format     Abstract available


  100. KIM SM, Kim YI, Park SJ, Kim EH, et al
    Vaccine efficacy of an inactivated, chimeric HA H9/H5N2 avian influenza virus and its suitability for the marker vaccine strategy.
    J Virol. 2017 Jan 11. pii: JVI.01693-16. doi: 10.1128/JVI.01693.
    PubMed     Text format     Abstract available


  101. NAITO T, Mori K, Ushirogawa H, Takizawa N, et al
    Generation of a genetically stable high-fidelity influenza vaccine strain.
    J Virol. 2017 Jan 4. pii: JVI.01073-16. doi: 10.1128/JVI.01073.
    PubMed     Text format     Abstract available


    December 2016
  102. LI C, Wang Z, Cao Y, Wang L, et al
    Screening for novel small molecule inhibitors targeting the assembling of influenza virus polymerase complex by a BiLC-based reporter system.
    J Virol. 2016 Dec 28. pii: JVI.02282-16. doi: 10.1128/JVI.02282.
    PubMed     Text format     Abstract available


  103. YANG L, Zhu W, Li X, Bo H, et al
    Genesis and dissemination of highly pathogenic H5N6 avian influenza viruses.
    J Virol. 2016 Dec 21. pii: JVI.02199-16. doi: 10.1128/JVI.02199.
    PubMed     Text format     Abstract available


  104. NOGALES A, Martinez-Sobrido L, Topham DJ, DeDiego ML, et al
    NS1 protein amino acid changes D189N and V194I affect interferon responses, thermosensitivity and virulence of circulating H3N2 human influenza A viruses.
    J Virol. 2016 Dec 21. pii: JVI.01930-16. doi: 10.1128/JVI.01930.
    PubMed     Text format     Abstract available


  105. NGUYEN DT, Jang Y, Nguyen TD, Jones J, et al
    Shifting clade distribution, reassortment, and emergence of new subtypes of highly pathogenic avian influenza A(H5) viruses collected in Vietnamese poultry from 2012 to 2015.
    J Virol. 2016 Dec 21. pii: JVI.01708-16. doi: 10.1128/JVI.01708.
    PubMed     Text format     Abstract available


  106. NOGALES A, Rodriguez L, Chauche C, Huang K, et al
    A temperature sensitive live-attenuated canine influenza virus H3N8 vaccine.
    J Virol. 2016 Dec 7. pii: JVI.02211.
    PubMed     Text format     Abstract available


  107. RAJAO DS, Walia R, Campbell B, Gauger PC, et al
    Reassortment between swine H3N2 and 2009 pandemic H1N1 in the United States resulted in influenza A viruses with diverse genetic constellations with variable virulence in pigs.
    J Virol. 2016 Dec 7. pii: JVI.01763.
    PubMed     Text format     Abstract available


    November 2016
  108. ZHANG S, Jiang Y, Cheng Q, Yi Z, et al
    Inclusion body fusion of human parainfluenza virus type 3 regulated by acetylated alpha-tubulin enhances viral replication.
    J Virol. 2016 Nov 23. pii: JVI.01802.
    PubMed     Text format     Abstract available


  109. MINAKUCHI M, Sugiyama K, Kato Y, Naito T, et al
    Pre-mRNA processing factor Prp18 is a stimulatory factor of influenza virus RNA synthesis and possesses the NP chaperone activity.
    J Virol. 2016 Nov 16. pii: JVI.01398.
    PubMed     Text format     Abstract available


  110. ZANIN M, Kocer ZA, Poulson RL, Gabbard JD, et al
    The Potential for Low Pathogenic Avian H7 Influenza A Viruses to Replicate and Cause Disease in a Mammalian Model.
    J Virol. 2016 Nov 16. pii: JVI.01934.
    PubMed     Text format     Abstract available


  111. MARVIN SA, Russier M, Huerta CT, Russell CJ, et al
    Influenza overcomes cellular blocks to productively replicate impacting macrophage function.
    J Virol. 2016 Nov 2. pii: JVI.01417.
    PubMed     Text format     Abstract available


  112. CROSBY CM, Matchett WE, Anguiano-Zarate SS, Parks CA, et al
    Replicating Single-cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses.
    J Virol. 2016 Nov 2. pii: JVI.00720.
    PubMed     Text format     Abstract available


  113. TANG Q, Wang X, Gao G
    ZAPS inhibits influenza A viral protein expression and is antagonized by the virus encoded NS1.
    J Virol. 2016 Nov 2. pii: JVI.01909.
    PubMed     Text format     Abstract available


  114. IWATSUKI-HORIMOTO K, Nakajima N, Shibata M, Takahashi K, et al
    Microminipigs as an animal model for influenza A virus infection.
    J Virol. 2016 Nov 2. pii: JVI.01716.
    PubMed     Text format     Abstract available


  115. WANG X, Ilyushina NA, Lugovtsev VY, Bovin NV, et al
    Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.
    J Virol. 2016 Nov 2. pii: JVI.01512.
    PubMed     Text format     Abstract available


    October 2016
  116. WANG J, Li J, Zhao L, Cao M, et al
    The dual roles of the HA segment-specific noncoding nucleotides in the extended duplex region of the influenza A virus RNA promoter.
    J Virol. 2016 Oct 26. pii: JVI.01931.
    PubMed     Text format     Abstract available


  117. TENG O, Chen ST, Hsu TL, Sia SF, et al
    CLEC5A-mediated enhancement of the inflammatory response in myeloid cells contributes to influenza pathogenicity in vivo.
    J Virol. 2016 Oct 19. pii: JVI.01813.
    PubMed     Text format     Abstract available


  118. ZHU P, Liang L, Shao X, Luo W, et al
    Host cellular protein TRAPPC6ADelta interacts with influenza A virus M2 protein and regulates viral propagation by modulating M2 trafficking.
    J Virol. 2016 Oct 19. pii: JVI.01757.
    PubMed     Text format     Abstract available


  119. TAKEMAE N, Harada M, Nguyen PT, Nguyen T, et al
    Vietnamese influenza A viruses of swine between 2010 and 2015: multiple introductions of A(H1N1)pdm09 viruses into the pig population and diversifying genetic constellations of enzootic IAV-S.
    J Virol. 2016 Oct 19. pii: JVI.01490.
    PubMed     Text format     Abstract available


  120. SOBEL LEONARD A, McClain MT, Smith GJ, Wentworth D, et al
    Deep Sequencing of Influenza A Virus from a Human Challenge Study Reveals a Selective Bottleneck and Only Limited Intrahost Genetic Diversification.
    J Virol. 2016 Oct 5. pii: JVI.01657.
    PubMed     Text format     Abstract available


  121. SUN X, Zeng H, Kumar A, Belser JA, et al
    Constitutively expressed IFITM3 protein in human pulmonary endothelial cells poses an early infection block to human influenza viruses.
    J Virol. 2016 Oct 5. pii: JVI.01254.
    PubMed     Text format     Abstract available


  122. RABBANI MA, Ribaudo M, Guo JT, Barik S, et al
    Identification of IFN-stimulated gene (ISG) proteins that inhibit human parainfluenza virus type 3.
    J Virol. 2016 Oct 5. pii: JVI.01551.
    PubMed     Text format     Abstract available


    September 2016
  123. NELSON MI, Stucker KM, Schobel SA, Trovao NS, et al
    Introduction, evolution, and dissemination of influenza A viruses in exhibition swine, USA, 2009-2013.
    J Virol. 2016 Sep 28. pii: JVI.01457.
    PubMed     Text format     Abstract available


  124. SUN X, Belser JA, Pulit-Penaloza JA, Zeng H, et al
    Pathogenesis and transmission assessments of two H7N8 influenza A viruses recently isolated from turkey farms in Indiana using mouse and ferret models.
    J Virol. 2016 Sep 28. pii: JVI.01646.
    PubMed     Text format     Abstract available


  125. KIRUI J, Mondal A, Mehle A
    Ubiquitination up-regulates influenza virus polymerase function.
    J Virol. 2016 Sep 28. pii: JVI.01829.
    PubMed     Text format     Abstract available


  126. WU Y, Gao F, Qi J, Bi Y, et al
    Resistance to mutant group-2 influenza neuraminidases of an oseltamivir-zanamivir hybrid inhibitor.
    J Virol. 2016 Sep 21. pii: JVI.01703.
    PubMed     Text format     Abstract available


  127. NURNBERGER C, Zimmermann V, Gerhardt M, Staeheli P, et al
    Influenza virus susceptibility of wild-derived CAST/EiJ mice results from two amino acid changes in the MX1 restriction factor.
    J Virol. 2016 Sep 21. pii: JVI.01213.
    PubMed     Text format     Abstract available


  128. MARJUKI H, Mishin VP, Chai N, Tan MW, et al
    Human monoclonal antibody 81.39a effectively neutralizes emerging influenza A viruses of group 1 and 2 hemagglutinins.
    J Virol. 2016 Sep 14. pii: JVI.01284.
    PubMed     Text format     Abstract available


  129. DINIS JM, Florek NW, Fatola OO, Moncla LH, et al
    Correction for Dinis et al., Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans.
    J Virol. 2016;90:8029.
    PubMed     Text format    


    August 2016
  130. ALTENBURG AF, van de Sandt CE, van Trierum SE, De Gruyter HL, et al
    Increased Protein Degradation Improves Influenza Virus Nucleoprotein-specific CD8+ T cell Activation in vitro but not in C57BL/6 mice.
    J Virol. 2016 Aug 31. pii: JVI.01633.
    PubMed     Text format     Abstract available


  131. FABRIZIO TP, Sun Y, Yoon SW, Jeevan T, et al
    Virologic differences do not fully explain the diversification of swine influenza viruses in the United States.
    J Virol. 2016 Aug 31. pii: JVI.01218.
    PubMed     Text format     Abstract available


  132. LIANG B, Ngwuta JO, Herbert R, Swerczek J, et al
    Packaging and prefusion stabilization separately and additively increase the quantity and quality of RSV-neutralizing antibodies induced by respiratory syncytial virus (RSV) fusion protein expressed by a parainfluenza vector.
    J Virol. 2016 Aug 31. pii: JVI.01196.
    PubMed     Text format     Abstract available


  133. PANTIN-JACKWOOD MJ, Costa-Hurtado M, Shepherd E, DeJesus E, et al
    Pathogenicity and transmission of H5 and H7 highly pathogenic avian influenza viruses in mallards.
    J Virol. 2016 Aug 24. pii: JVI.01165.
    PubMed     Text format     Abstract available


  134. RANADHEERA C, Hagan MW, Leung A, Collignon B, et al
    Reduction of neuraminidase activity exacerbates disease in 2009 pandemic influenza virus-infected mice.
    J Virol. 2016 Aug 24. pii: JVI.01188.
    PubMed     Text format     Abstract available


  135. LIU L, Zeng X, Chen P, Deng G, et al
    Characterization of Clade 7.2 H5 Avian Influenza Viruses That Continue to Circulate in Chickens in China.
    J Virol. 2016 Aug 24. pii: JVI.00855.
    PubMed     Text format     Abstract available


  136. TENG Q, Xu D, Shen W, Liu Q, et al
    A Single Mutation at Position 190 in Hemagglutinin Enhances Binding Affinity for Human Type Sialic Acid Receptor and Replication of H9N2 Avian Influenza Virus in Mice.
    J Virol. 2016 Aug 24. pii: JVI.01141.
    PubMed     Text format     Abstract available


  137. DEDIEGO ML, Nogales A, Lambert-Emo K, Martinez-Sobrido L, et al
    An NS1 protein mutation (I64T) affects interferon responses and virulence of circulating H3N2 human influenza A viruses.
    J Virol. 2016 Aug 17. pii: JVI.01039.
    PubMed     Text format     Abstract available


  138. HURT AC, Su YC, Aban M, Peck H, et al
    Evidence for the introduction, reassortment and persistence of diverse influenza A viruses in Antarctica.
    J Virol. 2016 Aug 17. pii: JVI.01404.
    PubMed     Text format     Abstract available


  139. DAI M, Guo H, Dortmans J, Dekkers J, et al
    Identification of residues that affect oligomerization and/or enzymatic activity of influenza virus H5N1 neuraminidase proteins.
    J Virol. 2016 Aug 10. pii: JVI.01346.
    PubMed     Text format     Abstract available


  140. OHTA K, Goto H, Matsumoto Y, Yumine N, et al
    Graf1 controls the growth of human parainfluenza virus type 2 through inactivation of RhoA signaling.
    J Virol. 2016 Aug 10. pii: JVI.01471.
    PubMed     Text format     Abstract available


  141. TALKER SC, Stadler M, Koinig HC, Mair KH, et al
    Influenza A virus infection in pigs attracts multifunctional and cross-reactive T cells to the lung.
    J Virol. 2016 Aug 10. pii: JVI.01211.
    PubMed     Text format     Abstract available


  142. KHURANA S, Chung KY, Coyle EM, Meijer A, et al
    Antigenic fingerprinting of antibody response following highly pathogenic H7N7 avian influenza virus exposure in humans: Evidence for anti-PA-X antibodies.
    J Virol. 2016 Aug 10. pii: JVI.01408.
    PubMed     Text format     Abstract available


  143. TURNBULL ML, Wise HM, Nicol MQ, Smith N, et al
    The Role of the B-Allele of the Influenza A Virus Segment 8 in Setting Mammalian Host Range and Pathogenicity.
    J Virol. 2016 Aug 3. pii: JVI.01205.
    PubMed     Text format     Abstract available


    July 2016
  144. LONG JC, Fodor E
    The PB2 subunit of the influenza A virus RNA polymerase is imported into the mitochondrial matrix.
    J Virol. 2016 Jul 20. pii: JVI.01384.
    PubMed     Text format     Abstract available


  145. WEBER-GERLACH M, Weber F
    To conquer the host, Influenza virus is packing it in: interferon-antagonistic strategies beyond NS1.
    J Virol. 2016 Jul 20. pii: JVI.00041.
    PubMed     Text format     Abstract available


  146. LIU WC, Jan JT, Huang YJ, Chen TH, et al
    Unmasking stem-specific neutralizing epitopes by abolishing N-linked glycosylation sites of influenza hemagglutinin proteins for vaccine design.
    J Virol. 2016 Jul 20. pii: JVI.00880.
    PubMed     Text format     Abstract available


  147. ZHOU B, Meliopoulos VA, Wang W, Lin X, et al
    Reversion of Cold-adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus.
    J Virol. 2016 Jul 20. pii: JVI.00163.
    PubMed     Text format     Abstract available


  148. MATSUZAKI Y, Sugawara K, Furuse Y, Shimotai Y, et al
    Genetic lineage and reassortment of influenza C viruses circulating between 1947 and 2014.
    J Virol. 2016 Jul 6. pii: JVI.00969.
    PubMed     Text format     Abstract available


  149. ABENTE EJ, Santos J, Lewis NS, Gauger PC, et al
    The molecular determinants of antibody recognition and antigenic drift in the H3 hemagglutinin of swine influenza A virus.
    J Virol. 2016 Jul 6. pii: JVI.01002.
    PubMed     Text format     Abstract available


  150. XU G, Zhang X, Gao W, Wang C, et al
    Prevailing PA mutation K356R in avian influenza H9N2 virus increases mammalian replication and pathogenicity.
    J Virol. 2016 Jul 6. pii: JVI.00883.
    PubMed     Text format     Abstract available


    June 2016
  151. DAM S, Kracht M, Pleschka S, Schmitz ML, et al
    The influenza A virus genotype determines the anti-viral function of NF-kappaB.
    J Virol. 2016 Jun 29. pii: JVI.00946.
    PubMed     Text format     Abstract available


  152. DIPIAZZA A, Richards K, Batarse F, Lockard L, et al
    Flow Cytometric and Cytokine ELISpot Approaches to Characterize the Cell-mediated Immune Response in Ferrets Following Influenza Virus Infection.
    J Virol. 2016 Jun 29. pii: JVI.01001.
    PubMed     Text format     Abstract available


  153. ROSTAD CA, Stobart CC, Gilbert BE, Pickles RJ, et al
    A recombinant respiratory syncytial virus vaccine candidate attenuated by a low-fusion F protein is immunogenic and protective against challenge in cotton rats.
    J Virol. 2016 Jun 8. pii: JVI.00012.
    PubMed     Text format     Abstract available


  154. WEISSHAAR M, Cox R, Morehouse Z, Kyasa S, et al
    Identification and Characterization of Influenza Virus Entry Inhibitors Through Dual-Myxovirus High-Throughput Screening.
    J Virol. 2016 Jun 1. pii: JVI.00898.
    PubMed     Text format     Abstract available


  155. PALOMO C, Mas V, Thom M, Vazquez M, et al
    Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses.
    J Virol. 2016;90:5485-98.
    PubMed     Text format     Abstract available


    May 2016
  156. HAYASHI T, Chaimayo C, McGuinness J, Takimoto T, et al
    Critical role of the PA-X C-terminal domain of influenza A virus on its subcellular localization and shutoff activity.
    J Virol. 2016 May 25. pii: JVI.00954.
    PubMed     Text format     Abstract available


  157. KO EJ, Lee YT, Kim KH, Jung YJ, et al
    MF59 adjuvant effects on inducing isotype-switched IgG antibodies and protection after immunization with T-dependent influenza virus vaccine in the absence of CD4+ T cells.
    J Virol. 2016 May 25. pii: JVI.00339.
    PubMed     Text format     Abstract available


  158. QUINONES-PARRA SM, Clemens EB, Wang Z, Croom HA, et al
    A role of influenza exposure history in determining pandemic susceptibility and CD8+ T cell responses.
    J Virol. 2016 May 25. pii: JVI.00349.
    PubMed     Text format     Abstract available


  159. GUI L, Ebner JL, Mileant A, Williams JA, et al
    Visualization and sequencing of membrane remodeling leading to influenza virus fusion.
    J Virol. 2016 May 25. pii: JVI.00240.
    PubMed     Text format     Abstract available


  160. KAMLANGDEE A, Kingstad-Bakke B, Osorio JE
    Mosaic H5 hemagglutinin provides broad humoral and cellular immune responses against influenza viruses.
    J Virol. 2016 May 18. pii: JVI.00730.
    PubMed     Text format     Abstract available


  161. LEE YT, Ko EJ, Lee Y, Lee YN, et al
    CD47 plays a role as a negative regulator in inducing protective immune responses to vaccination against influenza virus.
    J Virol. 2016 May 18. pii: JVI.00605.
    PubMed     Text format     Abstract available


  162. SHARMA A, Wu W, Sung B, Huang J, et al
    Respiratory Syncytial Virus (RSV) Pulmonary Infection in Humanized Mice Induces Human Anti-RSV Immune Responses and Pathology.
    J Virol. 2016;90:5068-74.
    PubMed     Text format     Abstract available


  163. OTIENO JR, Agoti CN, Gitahi CW, Bett A, et al
    Molecular Evolutionary Dynamics of Respiratory Syncytial Virus Group A in Recurrent Epidemics in Coastal Kenya.
    J Virol. 2016;90:4990-5002.
    PubMed     Text format     Abstract available


  164. ALJABR W, Touzelet O, Pollakis G, Wu W, et al
    Investigating the Influence of Ribavirin on Human Respiratory Syncytial Virus RNA Synthesis by Using a High-Resolution Transcriptome Sequencing Approach.
    J Virol. 2016;90:4876-88.
    PubMed     Text format     Abstract available


  165. FAN S, Wu Y, Wang S, Wang Z, et al
    Structural and biochemical analyses of swine MHC class I complexes and prediction of the epitope map in important influenza A strains.
    J Virol. 2016 May 11. pii: JVI.00119.
    PubMed     Text format     Abstract available


  166. HOA LN, Mai LQ, Bryant JE, Thai PQ, et al
    Association between HA stem-reactive antibodies and influenza A/H1N1 infection during the 2009 pandemic.
    J Virol. 2016 May 11. pii: JVI.00093.
    PubMed     Text format     Abstract available


  167. FUSARO A, Tassoni L, Milani A, Hughes J, et al
    Unexpected Inter-farm Transmission Dynamics During a Highly Pathogenic Avian Influenza Epidemic.
    J Virol. 2016 May 4. pii: JVI.00538.
    PubMed     Text format     Abstract available


    April 2016
  168. NOGALES A, DeDiego ML, Topham DJ, Martinez-Sobrido L, et al
    Rearrangement of influenza virus spliced segments for the development of live attenuated vaccines.
    J Virol. 2016 Apr 27. pii: JVI.00410.
    PubMed     Text format     Abstract available


  169. JIANG J, Li J, Fan W, Zheng W, et al
    Robust Lys63-linked Ubiquitination of RIG-I Promotes Cytokine Eruption in Early Influenza B Virus Infection.
    J Virol. 2016 Apr 27. pii: JVI.00549.
    PubMed     Text format     Abstract available


  170. SUN H, Pu J, Wei Y, Sun Y, et al
    Highly pathogenic avian influenza H5N6 viruses exhibit enhanced affinity for human type sialic acid receptor and in-contact transmission in model ferrets.
    J Virol. 2016 Apr 27. pii: JVI.00127.
    PubMed     Text format     Abstract available


  171. LIU WC, Lin YL, Spearman M, Cheng PY, et al
    Influenza Hemagglutinin Glycoproteins with Different N-glycan Patterns Activate Dendritic Cells in Vitro.
    J Virol. 2016 Apr 20. pii: JVI.00452.
    PubMed     Text format     Abstract available


  172. MARTINEZ-ALONSO M, Hengrung N, Fodor E
    RNA-free and ribonucleoprotein-associated influenza virus polymerases directly bind the serine-5 phosphorylated carboxyl-terminal domain of host RNA polymerase II.
    J Virol. 2016 Apr 20. pii: JVI.00494.
    PubMed     Text format     Abstract available


  173. MANZ B, de Graaf M, Mogling R, Richard M, et al
    Multiple Natural Substitutions in Avian Influenza A Virus PB2 Facilitate Efficient Replication in Human Cells.
    J Virol. 2016 Apr 13. pii: JVI.00130.
    PubMed     Text format     Abstract available


  174. YANG H, Carney PJ, Mishin VP, Guo Z, et al
    The molecular characterizations of surface proteins hemagglutinin and neuraminidase from recent H5Nx avian influenza viruses.
    J Virol. 2016 Apr 6. pii: JVI.00180.
    PubMed     Text format     Abstract available


  175. KRISTENSEN AB, Lay WN, Ana-Sosa-Batiz F, Vanderven HA, et al
    Antibody responses with Fc-mediated functions after trivalent influenza vaccination of HIV-infected subjects.
    J Virol. 2016 Apr 6. pii: JVI.00285.
    PubMed     Text format     Abstract available


    March 2016
  176. FERGUSON L, Olivier AK, Genova S, Epperson WB, et al
    Pathogenesis of Influenza D virus in Cattle.
    J Virol. 2016 Mar 30. pii: JVI.03122.
    PubMed     Text format     Abstract available


  177. WANG D, Yang L, Zhu W, Zhang Y, et al
    Two outbreak sources of influenza A (H7N9) viruses have been established in China.
    J Virol. 2016 Mar 30. pii: JVI.03173.
    PubMed     Text format     Abstract available


  178. WILLIAMS GD, Pinto AK, Doll B, Boon AC, et al
    A North American H7N3 influenza virus supports reassortment with 2009 pandemic H1N1 and induces disease in mice without prior adaptation.
    J Virol. 2016 Mar 2. pii: JVI.02761.
    PubMed     Text format     Abstract available


  179. ZANG N, Zhuang J, Deng Y, Yang Z, et al
    Pulmonary C Fibers Modulate MMP-12 Production via PAR2 and Are Involved in the Long-Term Airway Inflammation and Airway Hyperresponsiveness Induced by Respiratory Syncytial Virus Infection.
    J Virol. 2015;90:2536-43.
    PubMed     Text format     Abstract available


  180. FORERO A, Tisoncik-Go J, Watanabe T, Zhong G, et al
    The 1918 Influenza Virus PB2 Protein Enhances Virulence through the Disruption of Inflammatory and Wnt-Mediated Signaling in Mice.
    J Virol. 2015;90:2240-53.
    PubMed     Text format     Abstract available


  181. EBERLE KC, McGill JL, Reinhardt TA, Sacco RE, et al
    Parainfluenza Virus 3 Blocks Antiviral Mediators Downstream of the Interferon Lambda Receptor by Modulating Stat1 Phosphorylation.
    J Virol. 2015;90:2948-58.
    PubMed     Text format     Abstract available


    February 2016
  182. NAGESH PT, Husain M
    Influenza A virus dysregulates host histone deacetylase 1 that inhibits viral infection in lung epithelial cells.
    J Virol. 2016 Feb 24. pii: JVI.00126.
    PubMed     Text format     Abstract available


  183. RUSSELL RF, McDonald JU, Lambert L, Tregoning JS, et al
    Use of the microparticle Nano-SiO2 as an adjuvant to boost vaccine immune responses in neonatal mice against influenza.
    J Virol. 2016 Feb 24. pii: JVI.03159.
    PubMed     Text format     Abstract available


  184. CARTER DM, Darby CA, LeFoley BC, Crevar CJ, et al
    Design and Characterization of a COBRA HA vaccine for H1N1 influenza viruses.
    J Virol. 2016 Feb 24. pii: JVI.03152.
    PubMed     Text format     Abstract available


  185. RUANGRUNG K, Suptawiwat O, Maneechotesuwan K, Boonarkart C, et al
    Neuraminidase Activity and The Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
    J Virol. 2016 Feb 24. pii: JVI.00013.
    PubMed     Text format     Abstract available


  186. BELSER JA, Creager HM, Sun X, Gustin KM, et al
    Mammalian pathogenesis and transmission of H7N9 influenza viruses from three waves, 2013-2015.
    J Virol. 2016 Feb 24. pii: JVI.00134.
    PubMed     Text format     Abstract available


  187. KUO RL, Li LH, Lin SJ, Li ZH, et al
    The role of N-terminus-truncated NS1 proteins of influenza A virus in inhibiting IRF3 activation.
    J Virol. 2016 Feb 24. pii: JVI.02843.
    PubMed     Text format     Abstract available


  188. KUHN N, Bergmann S, Kasnitz N, Lambertz RL, et al
    The proteolytic activation of A (H3N2) Influenza virus hemagglutinin is facilitated by different type II transmembrane serine proteases.
    J Virol. 2016 Feb 17. pii: JVI.02693.
    PubMed     Text format     Abstract available


  189. LIU B, Li NL, Shen Y, Bao X, et al
    The C-terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.
    J Virol. 2016 Feb 17. pii: JVI.03172.
    PubMed     Text format     Abstract available


  190. FUJIMOTO Y, Ito H, Ono E, Kawaoka Y, et al
    The low-pH resistance of neuraminidase is essential for the replication of influenza A virus in duck intestine following infection via the oral route.
    J Virol. 2016 Feb 10. pii: JVI.03107.
    PubMed     Text format     Abstract available


  191. MORIYAMA M, Chen IY, Kawaguchi A, Koshiba T, et al
    The RNA- and TRIM25-binding domains of influenza virus NS1 protein are essential for suppression of NLRP3 inflammasome-mediated IL-1beta secretion.
    J Virol. 2016 Feb 10. pii: JVI.00120.
    PubMed     Text format     Abstract available


  192. ZHANG J, Huang F, Tan L, Bai C, et al
    MOV10 is a Restriction Factor of Influenza A Virus by Inhibiting the Nuclear Import of the Viral Nucleoprotein.
    J Virol. 2016 Feb 3. pii: JVI.03137.
    PubMed     Text format     Abstract available


  193. EDENBOROUGH KM, Lowther S, Laurie K, Yamada M, et al
    Predicting Disease Severity and Viral Spread of H5N1 Influenza Virus in Ferrets in the Context of Natural Exposure Routes.
    J Virol. 2015;90:1888-97.
    PubMed     Text format     Abstract available


    January 2016
  194. BODEWES R, Zohari S, Krog JS, Hall MD, et al
    Spatiotemporal analysis of the genetic diversity of seal influenza A(H10N7) virus, Northwestern Europe.
    J Virol. 2016 Jan 27. pii: JVI.03046.
    PubMed     Text format     Abstract available


  195. MARCOS-VILLAR L, Pazo A, Nieto A
    Influenza virus and the chromatin: Role of CHD1 chromatin remodeler on virus life cycle.
    J Virol. 2016 Jan 20. pii: JVI.00053.
    PubMed     Text format     Abstract available


  196. MEYER L, Sausset A, Sedano L, Da Costa B, et al
    Codon deletions in the influenza A virus PA gene generate temperature-sensitive viruses.
    J Virol. 2016 Jan 20. pii: JVI.03101.
    PubMed     Text format     Abstract available


  197. THULASI RAMAN SN, Liu G, Pyo HM, Cui YC, et al
    DDX3 interacts with influenza A NS1 and NP proteins and exerts antiviral function through regulation of stress granule formation.
    J Virol. 2016 Jan 20. pii: JVI.03010.
    PubMed     Text format     Abstract available


  198. SCHRAUWEN EJ, Richard M, Burke DF, Rimmelzwaan GF, et al
    Amino acid substitutions that affect receptor binding and stability of the hemagglutinin of influenza A/H7N9 virus.
    J Virol. 2016 Jan 20. pii: JVI.03052.
    PubMed     Text format     Abstract available


  199. MOORE IN, Lamirande EW, Paskel M, Donahue D, et al
    Correction for Moore et al., Severity of Clinical Disease and Pathology in Ferrets Experimentally Infected with Influenza Viruses Is Influenced by Inoculum Volume.
    J Virol. 2015;90:1153.
    PubMed     Text format    


  200. CHEN CJ, Ermler ME, Tan GS, Krammer F, et al
    Influenza A viruses expressing intra- or inter-group chimeric hemagglutinins.
    J Virol. 2016 Jan 13. pii: JVI.03060.
    PubMed     Text format     Abstract available


  201. WANG J, Wu M, Hong W, Fan X, et al
    Infectivity and Transmissibility of Avian H9N2 Influenza Viruses in Pigs.
    J Virol. 2016 Jan 13. pii: JVI.02605.
    PubMed     Text format     Abstract available


  202. GONZALEZ-SANZ R, Mata M, Bermejo-Martin J, Alvarez A, et al
    ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation.
    J Virol. 2016;90:3428-38.
    PubMed     Text format     Abstract available


  203. MARTIN V, Pascual E, Avia M, Rangel G, et al
    A recombinant adenovirus expressing ovine interferon-tau prevents influenza virus induced lethality in mice.
    J Virol. 2016 Jan 6. pii: JVI.03258.
    PubMed     Text format     Abstract available


  204. DINIS JM, Florek NW, Fatola OO, Moncla LH, et al
    Deep sequencing reveals potential antigenic variants at low frequency in influenza A-infected humans.
    J Virol. 2016 Jan 6. pii: JVI.03248.
    PubMed     Text format     Abstract available


  205. SONG MS, Baek YH, Pascua PN, Kwon HI, et al
    Growth and Pathogenic Potential of Naturally Selected Reassortants after Coinfection with Pandemic H1N1 and Highly Pathogenic Avian Influenza H5N1 Viruses.
    J Virol. 2015;90:616-23.
    PubMed     Text format     Abstract available


  206. MENG J, Hotard AL, Currier MG, Lee S, et al
    Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein.
    J Virol. 2015;90:245-53.
    PubMed     Text format     Abstract available


  207. YOU D, Saravia J, Siefker D, Shrestha B, et al
    Crawling with Virus: Translational Insights from a Neonatal Mouse Model on the Pathogenesis of Respiratory Syncytial Virus in Infants.
    J Virol. 2015;90:2-4.
    PubMed     Text format     Abstract available


    December 2015
  208. HEMANN EA, Sjaastad LE, Langlois RA, Legge KL, et al
    Plasmacytoid dendritic cells require direct infection to sustain the pulmonary influenza A virus-specific CD8 T cell response.
    J Virol. 2015 Dec 30. pii: JVI.02546.
    PubMed     Text format     Abstract available


  209. HANSON A, Imai M, Hatta M, McBride R, et al
    Identification of Stabilizing Mutations in an H5 HA Influenza Virus Protein.
    J Virol. 2015 Dec 30. pii: JVI.02790.
    PubMed     Text format     Abstract available


  210. CAROLAN LA, Rockman S, Borg K, Guarnaccia T, et al
    Characterisation of the localised immune response in the respiratory tract of ferrets following infection with influenza A and B viruses.
    J Virol. 2015 Dec 30. pii: JVI.02797.
    PubMed     Text format     Abstract available


  211. NACHBAGAUER R, Miller MS, Hai R, Ryder AB, et al
    Hemagglutinin stalk immunity reduces influenza virus replication and transmission in ferrets.
    J Virol. 2015 Dec 30. pii: JVI.02481.
    PubMed     Text format     Abstract available


  212. WANG L, Wu A, Wang YE, Quanquin N, et al
    Functional Genomics Reveals Linkers Critical for Influenza Polymerase.
    J Virol. 2015 Dec 30. pii: JVI.02400.
    PubMed     Text format     Abstract available


  213. FEARS R, Ter Meulen V
    European academies advise on Gain of Function studies in influenza virus research.
    J Virol. 2015 Dec 23. pii: JVI.03045.
    PubMed     Text format     Abstract available


  214. RYDER AB, Nachbagauer R, Buonocore L, Palese P, et al
    Vaccination with VSV-vectored chimeric hemagglutinins protects mice against divergent influenza virus challenge strains.
    J Virol. 2015 Dec 16. pii: JVI.02598.
    PubMed     Text format     Abstract available


  215. LAI KK, Cheung NN, Yang F, Dai J, et al
    Identification of Novel Fusion Inhibitors of Influenza A Virus by Chemical Genetics.
    J Virol. 2015 Dec 16. pii: JVI.02326.
    PubMed     Text format     Abstract available


  216. XIA C, Vijayan M, Pritzl CJ, Fuchs SY, et al
    Hemagglutinin of influenza A virus antagonizes type I IFN responses by inducing degradation of type I IFN receptor 1.
    J Virol. 2015 Dec 16. pii: JVI.02749.
    PubMed     Text format     Abstract available


  217. COX A, Dewhurst S
    A single mutation at PB1 residue 319 dramatically increases the safety of PR8 LAIV in a murine model without compromising vaccine efficacy.
    J Virol. 2015 Dec 16. pii: JVI.02723.
    PubMed     Text format     Abstract available


  218. ZHANG G, Zhong Y, Qin Y, Chen M, et al
    Nucleoprotein of Human Parainfluenza Virus Type 3 interaction with Matrix protein Mediates Internal Viral Protein Assembly.
    J Virol. 2015 Dec 9. pii: JVI.02324.
    PubMed     Text format     Abstract available


  219. KANG MC, Choi DH, Choi YW, Park SJ, et al
    Intranasal introduction of Fc-fused interleukin-7 provides long-lasting prophylaxis from lethal influenza infection.
    J Virol. 2015 Dec 9. pii: JVI.02768.
    PubMed     Text format     Abstract available


  220. FENG X, Wang Z, Shi J, Deng G, et al
    Glycine at position 622 in PB1 contributes to the virulence of H5N1 avian influenza virus in mice.
    J Virol. 2015 Dec 9. pii: JVI.02387.
    PubMed     Text format     Abstract available


  221. NAKAMURA S, Horie M, Daidoji T, Honda T, et al
    Influenza A virus-induced expression of a GalNAc transferase, GALNT3, via miRNAs is required for enhanced viral replication.
    J Virol. 2015 Dec 4. pii: JVI.02246.
    PubMed     Text format     Abstract available


  222. SUGIYAMA M, Gamage A, Zyla R, Armstrong SM, et al
    Influenza infection induces platelet-endothelial adhesion which contributes to lung injury.
    J Virol. 2015 Dec 4. pii: JVI.02599.
    PubMed     Text format     Abstract available


  223. VILLENAVE R, Broadbent L, Douglas I, Lyons JD, et al
    Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.
    J Virol. 2015;89:12309-18.
    PubMed     Text format     Abstract available


    November 2015
  224. BAUMANN J, Mounogou Kouassi N, Foni E, Klenk HD, et al
    H1N1 Swine Influenza Viruses Differ from Avian Precursors by a higher pH Optimum of Membrane Fusion.
    J Virol. 2015 Nov 25. pii: JVI.02332.
    PubMed     Text format     Abstract available


  225. LIANG L, Deng G, Shi J, Wang S, et al
    Genetics, receptor binding, replication and transmission in mammals of H4 avian influenza viruses isolated from live poultry markets in China.
    J Virol. 2015 Nov 18. pii: JVI.02692.
    PubMed     Text format     Abstract available


  226. KIRCHENBAUM GA, Carter DM, Ross TM
    Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Boosts Hemagglutinin Stalk-Specific Antibodies.
    J Virol. 2015 Nov 11. pii: JVI.02372.
    PubMed     Text format     Abstract available


  227. VAN DE SANDT CE, Kreijtz JH, Geelhoed-Mieras MM, Nieuwkoop NJ, et al
    Differential recognition of influenza A viruses by M158-66 epitope-specific CD8+ T cells is determined by extra-epitopic amino acid residues.
    J Virol. 2015 Nov 4. pii: JVI.02439.
    PubMed     Text format     Abstract available


  228. KOOPMAN G, Mooij P, Dekking L, Mortier D, et al
    Correlation between virus replication and antibody responses in macaques following infection with pandemic influenza A virus.
    J Virol. 2015 Nov 4. pii: JVI.02757.
    PubMed     Text format     Abstract available


  229. OUIZOUGUN-OUBARI M, Pereira N, Tarus B, Galloux M, et al
    A Druggable Pocket at the Nucleocapsid/Phosphoprotein Interaction Site of Human Respiratory Syncytial Virus.
    J Virol. 2015;89:11129-43.
    PubMed     Text format     Abstract available


  230. AGOTI CN, Otieno JR, Ngama M, Mwihuri AG, et al
    Successive Respiratory Syncytial Virus Epidemics in Local Populations Arise from Multiple Variant Introductions, Providing Insights into Virus Persistence.
    J Virol. 2015;89:11630-42.
    PubMed     Text format     Abstract available


    October 2015
  231. WOHLBOLD TJ, Chromikova V, Tan GS, Meade P, et al
    Hemagglutinin stalk- and neuraminidase-specific monoclonal antibodies protect against lethal H10N8 influenza virus infection in mice.
    J Virol. 2015 Oct 28. pii: JVI.02275.
    PubMed     Text format     Abstract available


  232. ABDELWHAB EM, Veits J, Tauscher K, Ziller M, et al
    A Unique Multibasic Proteolytic Cleavage Site and Three Mutations in the HA2 Domain Confer High Virulence of H7N1 Avian Influenza Virus in Chickens.
    J Virol. 2015 Oct 21. pii: JVI.02082.
    PubMed     Text format     Abstract available


  233. YAMAYOSHI S, Watanabe M, Goto H, Kawaoka Y, et al
    Identification of A Novel Viral Protein Expressed from the PB2 Segment of Influenza A Virus.
    J Virol. 2015 Oct 21. pii: JVI.02175.
    PubMed     Text format     Abstract available


  234. BATISHCHEV OV, Shilova LA, Kachala MV, Tashkin VY, et al
    pH-Dependent Formation and Disintegration of the Influenza A Virus Protein Scaffold to Provide Tension for Membrane Fusion.
    J Virol. 2015 Oct 14. pii: JVI.01539.
    PubMed     Text format     Abstract available


  235. BRAZZOLI M, Magini D, Bonci A, Buccato S, et al
    Induction of broad-based immunity and protective efficacy by self-amplifying mRNA vaccines encoding influenza virus hemagglutinin.
    J Virol. 2015 Oct 14. pii: JVI.01786.
    PubMed     Text format     Abstract available


  236. NG WC, Londrigan SL, Nasr N, Cunningham AL, et al
    The C-type lectin langerin functions as a receptor for attachment and infectious entry of influenza A virus.
    J Virol. 2015 Oct 14. pii: JVI.01447.
    PubMed     Text format     Abstract available


  237. DEVENTHIRAN J, Kumar SR, Raghunath S, Elankumaran S, et al
    PB1-F2 Protein does not impact the Virulence of Triple Reassortant H3N2 Swine Influenza Virus in Pigs but Alters the Pathogenicity and Transmission in Turkeys.
    J Virol. 2015 Oct 14. pii: JVI.01551.
    PubMed     Text format     Abstract available


  238. BLYTH GA, Chan WF, Webster RG, Magor KE, et al
    Duck IFITM3 mediates restriction of influenza viruses.
    J Virol. 2015 Oct 14. pii: JVI.01593.
    PubMed     Text format     Abstract available


  239. JIANG L, Fantoni G, Couzens L, Gao J, et al
    Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.
    J Virol. 2015 Oct 14. pii: JVI.01756.
    PubMed     Text format     Abstract available


  240. CHO KJ, Schepens B, Moonens K, Deng L, et al
    Crystal structure of the conserved amino-terminus of the extracellular domain of matrix protein 2 of influenza A virus gripped by an antibody.
    J Virol. 2015 Oct 14. pii: JVI.02105.
    PubMed     Text format     Abstract available


  241. REN Y, Li C, Feng L, Pan W, et al
    Proton channel activity of influenza A virus matrix protein 2 contributes to autophagy arrest.
    J Virol. 2015 Oct 14. pii: JVI.00576.
    PubMed     Text format     Abstract available


  242. ANCHISI S, Guerra J, Mottet-Osman G, Garcin D, et al
    Mismatches in Influenza A virus vRNA panhandle prevent RIG-I sensing by impairing RNA/RIG-I complex formation.
    J Virol. 2015 Oct 7. pii: JVI.01671.
    PubMed     Text format     Abstract available


  243. DHAR J, Cuevas RA, Goswami R, Zhu J, et al
    2'-5'-Oligoadenylate Synthetase-Like Protein Inhibits Respiratory Syncytial Virus Replication and Is Targeted by the Viral Nonstructural Protein 1.
    J Virol. 2015;89:10115-9.
    PubMed     Text format     Abstract available


    September 2015
  244. TSURUDOME M, Ito M, Ohtsuka J, Hara K, et al
    The fusion protein specificity of the parainfluenza virus hemagglutinin-neuraminidase protein is not solely defined by the primary structure of its stalk domain.
    J Virol. 2015 Sep 30. pii: JVI.01448.
    PubMed     Text format     Abstract available


  245. LONDRIGAN SL, Short KR, Ma J, Gillespie L, et al
    Infection of mouse macrophages by seasonal influenza viruses can be restricted at the level of virus entry and at late stage in the virus life cycle.
    J Virol. 2015 Sep 30. pii: JVI.01455.
    PubMed     Text format     Abstract available


  246. FULTON BO, Palese P, Heaton NS
    Replication competent influenza B reporter viruses as tools for screening antivirals and antibodies.
    J Virol. 2015 Sep 23. pii: JVI.02164.
    PubMed     Text format     Abstract available


  247. TRAVANTY E, Zhou B, Zhang H, Di YP, et al
    Differential susceptibility of human lung primary cells to H1N1 influenza viruses.
    J Virol. 2015 Sep 16. pii: JVI.01792.
    PubMed     Text format     Abstract available


  248. VAN POUCKE S, Doedt J, Baumann J, Qiu Y, et al
    Role of Substitutions in the Hemagglutinin in the Emergence of the 1968 Pandemic Influenza Virus.
    J Virol. 2015 Sep 16. pii: JVI.01292.
    PubMed     Text format     Abstract available


  249. YANG Y, Zengel J, Sun M, Sleeman K, et al
    Regulation Of Viral RNA Synthesis By The V Protein Of Parainfluenza Virus 5.
    J Virol. 2015 Sep 16. pii: JVI.01832.
    PubMed     Text format     Abstract available


  250. SREENIVASAN C, Thomas M, Sheng Z, Hause BM, et al
    Replication and transmission of novel bovine influenza D virus in guinea pig model.
    J Virol. 2015 Sep 16. pii: JVI.01630.
    PubMed     Text format     Abstract available


  251. MAKELA SM, Osterlund P, Westenius V, Latvala S, et al
    RIG-I Signaling Is Essential For Influenza B Virus-Induced Rapid Interferon Gene Expression.
    J Virol. 2015 Sep 16. pii: JVI.01576.
    PubMed     Text format     Abstract available


  252. KIM KH, Lee YT, Hwang HS, Kwon YM, et al
    Virus-like particle vaccine containing the F protein of respiratory syncytial virus confers protection without pulmonary disease by modulating specific subsets of dendritic cells and effector T cells.
    J Virol. 2015 Sep 9. pii: JVI.02018.
    PubMed     Text format     Abstract available


  253. VERHAGEN JH, Hofle U, van Amerongen G, van de Bildt M, et al
    Long-term effect of serial infections with H13 and H16 low pathogenic avian influenza viruses in black-headed gulls.
    J Virol. 2015 Sep 2. pii: JVI.01765.
    PubMed     Text format     Abstract available


  254. ZHAO D, Fukuyama S, Yamada S, Lopes TJ, et al
    Molecular determinants of virulence and stability of a reporter-expressing H5N1 influenza A virus.
    J Virol. 2015 Sep 2. pii: JVI.01886.
    PubMed     Text format     Abstract available


    August 2015
  255. RAJAO DS, Gauger PC, Anderson TK, Lewis NS, et al
    Novel reassortant human-like H3N2 and H3N1 influenza A viruses detected in pigs are virulent and antigenically distinct from endemic viruses.
    J Virol. 2015 Aug 26. pii: JVI.01675.
    PubMed     Text format     Abstract available


  256. SOLORZANO A, Foni E, Cordoba L, Baratelli M, et al
    Cross-species infectivity of H3N8 influenza virus in an experimental infection in swine.
    J Virol. 2015 Aug 26. pii: JVI.01509.
    PubMed     Text format     Abstract available


  257. REJMANEK D, Hosseini PR, Mazet JA, Daszak P, et al
    Evolutionary dynamics and global diversity of influenza A virus.
    J Virol. 2015 Aug 26. pii: JVI.01573.
    PubMed     Text format     Abstract available


  258. MACHKOVECH HM, Bedford T, Suchard MA, Bloom JD, et al
    Positive selection in CD8+ T-cell epitopes of influenza nucleoprotein revealed by a comparative analysis of human and swine viral lineages.
    J Virol. 2015 Aug 26. pii: JVI.01571.
    PubMed     Text format     Abstract available


  259. SU WC, Hsu SF, Lee YY, Jeng KS, et al
    A Nucleolar Protein, Ribosomal RNA Processing 1 Homolog B (RRP1B), Enhances the Recruitment of Cellular mRNA in Influenza Virus Transcription.
    J Virol. 2015 Aug 26. pii: JVI.01487.
    PubMed     Text format     Abstract available


  260. SONG MS, Marathe BM, Kumar G, Wong SS, et al
    Unique determinants of neuraminidase inhibitor resistance among N3, N7, and N9 avian influenza viruses.
    J Virol. 2015 Aug 19. pii: JVI.01514.
    PubMed     Text format     Abstract available


  261. VERHELST J, Spitaels J, Nurnberger C, De Vlieger D, et al
    Functional comparison of Mx1 from two different mouse species reveals the involvement of loop L4 in the antiviral activity against influenza A viruses.
    J Virol. 2015 Aug 19. pii: JVI.01744.
    PubMed     Text format     Abstract available


  262. BELJANSKI V, Chiang C, Kirchenbaum GA, Olagnier D, et al
    Enhanced influenza VLP vaccination with a structurally optimized RIG-I agonist as adjuvant.
    J Virol. 2015 Aug 12. pii: JVI.01526.
    PubMed     Text format     Abstract available


  263. FAN RL, Valkenburg SA, Wong CK, Li OT, et al
    Generation of live attenuated influenza virus using codon usage bias.
    J Virol. 2015 Aug 12. pii: JVI.01443.
    PubMed     Text format     Abstract available


  264. WANG W, DeFeo CJ, Alvarado E, Vassell R, et al
    Intermonomer Interactions in Hemagglutinin subunits HA1 and HA2 Affecting Hemagglutinin Stability and Influenza Virus Infectivity.
    J Virol. 2015 Aug 12. pii: JVI.00939.
    PubMed     Text format     Abstract available


  265. DIEDERICH S, Berhane Y, Embury-Hyatt C, Hisanaga T, et al
    Hemagglutinin-Neuraminidase Balance Influences the Virulence Phenotype of a Recombinant H5N3 Influenza A Virus Possessing a Polybasic HA0 Cleavage Site.
    J Virol. 2015 Aug 5. pii: JVI.01238.
    PubMed     Text format     Abstract available


  266. JU X, Yan Y, Liu Q, Li N, et al
    Neuraminidase of influenza A virus binds LAMPs directly and induces lysosome rupture.
    J Virol. 2015 Aug 5. pii: JVI.01411.
    PubMed     Text format     Abstract available


  267. TURKINGTON HL, Juozapaitis M, Kerry PS, Aydillo T, et al
    Novel Bat Influenza Virus NS1 Proteins Bind Double-Stranded RNA and Antagonize Host Innate Immunity.
    J Virol. 2015 Aug 5. pii: JVI.01430.
    PubMed     Text format     Abstract available


  268. GUO X, Liu T, Shi H, Wang J, et al
    Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.
    J Virol. 2015;89:7636-45.
    PubMed     Text format     Abstract available


  269. TRENTO A, Abrego L, Rodriguez-Fernandez R, Gonzalez-Sanchez MI, et al
    Conservation of G-Protein Epitopes in Respiratory Syncytial Virus (Group A) Despite Broad Genetic Diversity: Is Antibody Selection Involved in Virus Evolution?
    J Virol. 2015;89:7776-85.
    PubMed     Text format     Abstract available


  270. NOTON SL, Nagendra K, Dunn EF, Mawhorter ME, et al
    Respiratory Syncytial Virus Inhibitor AZ-27 Differentially Inhibits Different Polymerase Activities at the Promoter.
    J Virol. 2015;89:7786-98.
    PubMed     Text format     Abstract available


    July 2015
  271. HARTMANN BM, Thakar J, Albrecht RA, Avey S, et al
    Human dendritic cell response signatures distinguish 1918, pandemic and seasonal H1N1 influenza viruses.
    J Virol. 2015 Jul 29. pii: JVI.01523.
    PubMed     Text format     Abstract available


  272. PULIT-PENALOZA JA, Sun X, Creager HM, Zeng H, et al
    Pathogenesis and transmission of novel HPAI H5N2 and H5N8 avian influenza viruses in ferrets and mice.
    J Virol. 2015 Jul 29. pii: JVI.01438.
    PubMed     Text format     Abstract available


  273. ZHENG M, Wang P, Song W, Lau SY, et al
    A14U Substitution in 3' Non-Coding Region of M vRNA Supports Replication of NS1-Deleted Influenza Virus by Modulating Alternative Splicing of M mRNAs.
    J Virol. 2015 Jul 29. pii: JVI.00919.
    PubMed     Text format     Abstract available


  274. MACKOW N, Amaro Carambot E, Liang B, Surman S, et al
    Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion F Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.
    J Virol. 2015 Jul 29. pii: JVI.01380.
    PubMed     Text format     Abstract available


  275. WATSON SJ, Langat P, Reid SM, Lam TT, et al
    Molecular Epidemiology and Evolution of Influenza Viruses Circulating within European Swine between 2009 and 2013.
    J Virol. 2015 Jul 22. pii: JVI.00840.
    PubMed     Text format     Abstract available


  276. LUK GS, Leung CY, Sia SF, Choy KT, et al
    Transmission of H7N9 influenza viruses with polymorphism at PB2 residue 627 in chickens and ferrets.
    J Virol. 2015 Jul 22. pii: JVI.01444.
    PubMed     Text format     Abstract available


  277. SHIN DL, Hatesuer B, Bergmann S, Nedelko T, et al
    Protection from severe influenza infections in mice carrying the Mx1 influenza resistance gene strongly depends on genetic background.
    J Virol. 2015 Jul 22. pii: JVI.01305.
    PubMed     Text format     Abstract available


  278. VER LS, Marcos-Villar L, Landeras-Bueno S, Nieto A, et al
    The cellular factor NXP2/MORC3 is a positive regulator for influenza virus multiplication.
    J Virol. 2015 Jul 22. pii: JVI.01530.
    PubMed     Text format     Abstract available


  279. LIANG B, Surman S, Amaro-Carambot E, Kabatova B, et al
    Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Pre-fusion F Protein Expressed by a Vaccine Candidate.
    J Virol. 2015 Jul 8. pii: JVI.01373.
    PubMed     Text format     Abstract available


  280. SAM IC, Su YC, Chan YF, Nor'E SS, et al
    Evolution of influenza B virus in Kuala Lumpur, Malaysia between 1995 and 2008.
    J Virol. 2015 Jul 1. pii: JVI.00708.
    PubMed     Text format     Abstract available


    June 2015
  281. GNIRSS K, Zmora P, Blazejewska P, Winkler M, et al
    Tetherin sensitivity of influenza A viruses is strain specific: Role of hemagglutinin and neuraminidase.
    J Virol. 2015 Jun 24. pii: JVI.00615.
    PubMed     Text format     Abstract available


  282. RESA-INFANTE P, Paterson D, Bonet J, Otte A, et al
    Targeting importin-alpha7 as a therapeutic approach against pandemic influenza viruses.
    J Virol. 2015 Jun 17. pii: JVI.00583.
    PubMed     Text format     Abstract available


  283. CHLANDA P, Schraidt O, Kummer S, Riches J, et al
    Structural analysis of the roles of influenza A virus membrane-associated proteins in assembly and morphology.
    J Virol. 2015 Jun 17. pii: JVI.00592.
    PubMed     Text format     Abstract available


  284. YU Y, Wang X, Jin T, Wang H, et al
    Newly-emergent highly pathogenic H5N9 subtype avian influenza A virus.
    J Virol. 2015 Jun 17. pii: JVI.00653.
    PubMed     Text format     Abstract available


  285. WANG J, Chen Z, Bao L, Zhang W, et al
    Characterization of Two Human Monoclonal Antibodies Neutralizing Influenza A H7N9 Viruses.
    J Virol. 2015 Jun 10. pii: JVI.01295.
    PubMed     Text format     Abstract available


  286. CAMP JV, Bagci U, Chu YK, Squier B, et al
    Lower Respiratory Tract Infection of the Ferret by 2009 H1N1 Pandemic Influenza A Virus Triggers Biphasic, Systemic and Local Neutrophil Recruitment.
    J Virol. 2015 Jun 10. pii: JVI.00817.
    PubMed     Text format     Abstract available


  287. SU S, Bi Y, Wong G, Gray GC, et al
    The epidemiology, evolution and recent outbreaks of avian influenza viruses in China: A Review.
    J Virol. 2015 Jun 10. pii: JVI.01034.
    PubMed     Text format     Abstract available


  288. OISHI K, Yamayoshi S, Kawaoka Y
    Mapping of a region of the PA-X protein of influenza A virus that is important for its shut-off activity.
    J Virol. 2015 Jun 3. pii: JVI.01132.
    PubMed     Text format     Abstract available


  289. TAO H, Li L, White MC, Steel J, et al
    Influenza A virus co-infection through transmission can support high levels of reassortment.
    J Virol. 2015 Jun 3. pii: JVI.01162.
    PubMed     Text format     Abstract available


    May 2015
  290. HAYASHI T, Wills S, Bussey KA, Takimoto T, et al
    Identification of influenza A virus PB2 residues involved in enhanced polymerase activity and virus growth in mammalian cells at low temperature.
    J Virol. 2015 May 27. pii: JVI.00901.
    PubMed     Text format     Abstract available


  291. SONG Y, Wang X, Zhang H, Tang X, et al
    Repeated Low-dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation.
    J Virol. 2015 May 20. pii: JVI.00976.
    PubMed     Text format     Abstract available


  292. DLUGOLENSKI D, Jones L, Howerth E, Wentworth D, et al
    Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression.
    J Virol. 2015;89:5651-67.
    PubMed     Text format     Abstract available


  293. LI H, Ma Y, Escaffre O, Ivanciuc T, et al
    Role of hydrogen sulfide in paramyxovirus infections.
    J Virol. 2015;89:5557-68.
    PubMed     Text format     Abstract available


    April 2015
  294. ZENG H, Belser JA, Goldsmith CS, Gustin KM, et al
    A(H7N9) virus results in early induction of proinflammatory cytokine responses in both human lung epithelial and endothelial cells and shows increased human adaptation compared with avian H5N1 virus.
    J Virol. 2015;89:4655-67.
    PubMed     Text format     Abstract available


  295. SCHIBLER M, Piuz I, Hao W, Tapparel C, et al
    Chimeric rhinoviruses obtained via genetic engineering or artificially induced recombination are viable only if the polyprotein coding sequence derives from the same species.
    J Virol. 2015;89:4470-80.
    PubMed     Text format     Abstract available


  296. AGOTI CN, Otieno JR, Munywoki PK, Mwihuri AG, et al
    Local evolutionary patterns of human respiratory syncytial virus derived from whole-genome sequencing.
    J Virol. 2015;89:3444-54.
    PubMed     Text format     Abstract available


  297. KOEL BF, Mogling R, Chutinimitkul S, Fraaij PL, et al
    Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses.
    J Virol. 2015;89:3763-75.
    PubMed     Text format     Abstract available


  298. TAN Y, Ng Q, Jia Q, Kwang J, et al
    A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.
    J Virol. 2015;89:3712-22.
    PubMed     Text format     Abstract available


    February 2015
  299. VAN DIEPEN A, Brand HK, de Waal L, Bijl M, et al
    Host Proteome Correlates of Vaccine-Mediated Enhanced Disease in a Mouse Model of Respiratory Syncytial Virus Infection.
    J Virol. 2015 Feb 18. pii: JVI.03630.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: